51 - Both 14-Day Reverse Hybrid and Concomitant Therapies Cure Most Patients with Helicobacter Pylori Infection in Populations with Moderate Antibiotic Resistane: A Randomized Controlled Trial

Helicobacter Pylori ◽

Controlled Trial ◽

Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.2000.00659.x ◽

2000 ◽

Vol 14 (1) ◽

pp. 97-101 ◽

Cited By ~ 11

Author(s):

Mao ◽

Lak ◽

Long ◽

Chung ◽

Thang ◽

...

Keyword(s):

Duodenal Ulcer ◽

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Randomized Controlled ◽

Bismuth Citrate

Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial

Journal of Digestive Diseases ◽

10.1111/1751-2980.12934 ◽

2020 ◽

Vol 21 (10) ◽

pp. 549-557

Author(s):

Chao Ran Ji ◽

Jing Liu ◽

Yue Yue Li ◽

Chen Qiao ◽

Jun Yan Qu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Medication History ◽

Quadruple Therapy ◽

Randomized Controlled ◽

Rescue Treatment ◽

Guided Therapy

Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial

Indian Journal of Gastroenterology ◽

10.1007/s12664-019-00949-4 ◽

2019 ◽

Vol 38 (4) ◽

pp. 325-331 ◽

Cited By ~ 1

Author(s):

Sanjeev Kumar Jha ◽

Manish K. Mishra ◽

Kuldeep Saharawat ◽

Praveen Jha ◽

Shubham Purkayastha ◽

...

Keyword(s):

Helicobacter Pylori ◽

Drug Therapy ◽

Controlled Trial ◽

Concomitant Therapy ◽

Open Label ◽

A randomized controlled trial of the efficacy of two weeks of omeprazole and clarithromycin vs. one week of omeprazole, clarithromicin and amoxicillin for cure of Helicobacter pylori infection in primary care: Preliminary results

Gastroenterology ◽

10.1016/s0016-5085(98)80334-x ◽

1998 ◽

Vol 114 ◽

pp. A83

Author(s):

X. Calvet ◽

Servei de Medicina ◽

Consorci Hospitalari del Parc Taulí ◽

MJ Cubells ◽

T López Lorente ◽

...

Keyword(s):

Primary Care ◽

Helicobacter Pylori ◽

Controlled Trial ◽

Preliminary Results ◽

Open-Label Randomized Controlled Trial of Vonoprazan and Esomeprazole in First-Line Triple Therapy Against Helicobacter Pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(17)31120-4 ◽

2017 ◽

Vol 152 (5) ◽

pp. S248

Author(s):

Hiroyuki Tamaki ◽

Masahiro Morita ◽

Teruyo Noda ◽

Masako Izuta ◽

Atsushi Kubo ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

First Line ◽

Open Label ◽

An open-label, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for Helicobacter pylori infection

10.26226/morressier.59a6b345d462b80290b547bd ◽

2017 ◽

Author(s):

Hiroyuki Tamaki

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

First Line ◽

Open Label ◽

Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial

Wiener klinische Wochenschrift ◽

10.1007/s00508-008-1122-2 ◽

2009 ◽

Vol 121 (1-2) ◽

pp. 47-52 ◽

Cited By ~ 15

Author(s):

Josip Bago ◽

Branko Pevec ◽

Monika Tomić ◽

Marinko Marušić ◽

Vinko Bakula ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-017-2281-0 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 4

Author(s):

Hyuk Lee ◽

◽

Beom Jin Kim ◽

Sang Gyun Kim ◽

Jin Il Kim ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Study Protocol ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

First Line Treatment

Su1281 – Tetracycline-Levofloxacin Quadruple Therapy Achieves a Higher Eradication Rate Than Amoxicillin-Levofloxacin Quadruple Therapy in the Second-Line Treatment of Helicobacter Pylori Infection — a Randomized Controlled Trial

Gastroenterology ◽

10.1016/s0016-5085(19)38206-x ◽

2019 ◽

Vol 156 (6) ◽

pp. S-529

Author(s):

Ping-I Hsu ◽

Deng-Chyang Wu ◽

Consortium Taiwan Acid-Related Disease and Microbiota (TARD-M)

Keyword(s):

Helicobacter Pylori ◽

Eradication Rate ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Randomized controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-esophageal reflux: Bristol Helicobacter Project

Obstetrics and Gynecology ◽

10.1097/01.aog.0000139790.30511.2e ◽

2004 ◽

Vol 104 (3) ◽

pp. 628

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Esophageal Reflux ◽